Mon, April 15, 2013
Fri, April 12, 2013
Thu, April 11, 2013
[ Thu, Apr 11th 2013 ] - Market Wire
15 PM EDT
Wed, April 10, 2013
Tue, April 9, 2013
[ Tue, Apr 09th 2013 ] - Market Wire
30 a.m. ET
Mon, April 8, 2013
Sat, April 6, 2013
Fri, April 5, 2013
Thu, April 4, 2013
Wed, April 3, 2013
Tue, April 2, 2013
Mon, April 1, 2013
Fri, March 29, 2013
Thu, March 28, 2013
Wed, March 27, 2013
Tue, March 26, 2013
Mon, March 25, 2013
[ Mon, Mar 25th 2013 ] - Market Wire
Health Canada Decision Appealed
Sun, March 24, 2013
Fri, March 22, 2013
Thu, March 21, 2013
Wed, March 20, 2013
[ Wed, Mar 20th 2013 ] - Market Wire
00am ET
Tue, March 19, 2013
Mon, March 18, 2013

KaloBios to Present at Future Leaders in the Biotech Industry Conference


//health-fitness.news-articles.net/content/2013/ .. -leaders-in-the-biotech-industry-conference.html
Published in Health and Fitness on Monday, April 1st 2013 at 13:15 GMT by Market Wire   Print publication without navigation


KaloBios to Present at Future Leaders in the Biotech Industry... -- SOUTH SAN FRANCISCO, Calif., April 1, 2013 /PRNewswire/ --

SOUTH SAN FRANCISCO, Calif., April 1, 2013 /PRNewswire/ -- KaloBios Pharmaceuticals (Nasdaq: KBIO) today announced that the company has been selected to present at the 2013 BioCentury-Thomson Reuters Future Leaders in the Biotech Industry Conference, to be held in New York City on April 5, 2013. KaloBios President and Chief Executive Officer, David W. Pritchard , will provide an overview of KaloBios and the company's three current clinical programs for its proprietary, patient-targeted monoclonal antibody therapeutics.

(Logo: [ http://photos.prnewswire.com/prnh/20130225/MM66380LOGO ])

Company Presentation:
When: Friday, April 5, 2013, 9:00 am EDT, Presentation Room 311
Where: Millennium Broadway Hotel and Conference Center, New York, NY

Webcast:
To access the live and archived audio webcast of the KaloBios Future Leaders presentation please log on through a link located in the Investors section of the KaloBios Pharmaceuticals website under the Events & Presentations tab: [ http://ir.kalobios.com/events.cfm ].

A replay of the webcast will be available one hour after the conclusion of the live event. 

About KaloBios

KaloBios Pharmaceuticals, Inc. is developing a portfolio of patient-targeted, first-in-class monoclonal antibodies to treat serious medical conditions with a primary clinical focus on respiratory diseases and cancer.  For more information on KaloBios Pharmaceuticals, please visit our web site at [ http://www.kalobios.com ].

 

Contact:

Jeffrey H. Cooper
Chief Financial Officer
KaloBios Pharmaceuticals, Inc.
(650) 243-3146
[ ir@kalobios.com ]

Media Contact:

Joan E. Kureczka
Kureczka/Martin Associates
Tel:  (415) 821-2413
Mobile: (415) 690-0210
[ Joan@Kureczka-Martin.com ]

SOURCE KaloBios Pharmaceuticals, Inc.



RELATED LINKS
[ http://www.kalobios.com ]

Publication Contributing Sources